Treatment cells with DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine reduced DNA methylation of SIX3 promoter and markedly enhanced its expression in glioblastoma cells (Fig. 1c). This evidence concerns the gene SIX3 and glioblastoma.